Phathom Pharmaceuticals Rises Almost 30% After $182 Million

(Bloomberg) -- Phathom Pharmaceuticals Inc. rose 29.5% after expanding its initial public offering to raise $182 million, adding to a wave of biomedical and biotechnology going public.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.